Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dahuang Lidan is a Traditional Chinese Medicine (TCM) formulation, typically administered as a tablet, used for the treatment of hepatobiliary disorders. It is an in-hospital preparation developed and utilized by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. The formulation is primarily composed of *Rheum palmatum* (Dahuang), *Scutellaria baicalensis* (Huangqin), and *Artemisia capillaris* (Yinchen), which are traditionally used to clear damp-heat, resolve jaundice, and promote bile flow. In clinical research, it is being evaluated for its efficacy in treating nonalcoholic fatty liver disease (NAFLD), where it is thought to modulate lipid metabolism and exert anti-inflammatory effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dahuang Lidan.